Intrinsiqq
Mineralys Therapeutics, Inc. logo

Mineralys Therapeutics, Inc. Intrinsic Value

MLYS

Compare

Mineralys Therapeutics fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Mineralys Therapeutics today, so there is nothing to project yet.

Peers

Pharmaceutical Preparations · Pick stocks to compare with MLYS

CompareIntrinsic value
INVAInnoviva Inc.
$18.41+0.00%60
PAHCPhibro Animal Health Corporation
$33.29-2.32%57
NUVBNuvation Bio Inc.
$3.80-0.26%10
RAREUltragenyx Pharmaceutical Inc.
$16.48-4.30%40
PRGOPerrigo Company plc
$15.94-0.62%17
RCUSArcus Biosciences Inc.
$15.62-1.01%10
XNCRXencor Inc.
$33.26-2.21%11
VRDNViridian Therapeutics Inc.
$29.93-4.80%40

Held by ETFs

MLYS is in 37 US ETFs. The largest of them, with MLYS's weight in each:

Spot a number that looks wrong? Check it in MLYS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing MLYS

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.